Women with HIV can benefit from cervical cancer vaccine, study finds

04/22/2014 | New York Times (tiered subscription model), The

Research published in the journal Clinical Infectious Diseases found that a vaccine for cervical cancer was effective in women with HIV and also offers some protection to women who already had a strain of the human papilloma virus that is responsible for cervical cancer. Researchers studied 319 women in the U.S., South Africa and Brazil and found that 90% of women with recent HIV cases developed antibodies after receiving the Gardasil vaccine, as did 75% of women whose HIV had developed into AIDS. In addition, women infected with one or more strains of HPV could still develop antibodies to other strains after receiving the vaccination.

View Full Article in:

New York Times (tiered subscription model), The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI